VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 106 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $781,143 | -45.2% | 50,922 | -15.1% | 0.00% | – |
| Q2 2023 | $1,426,734 | +13.6% | 59,972 | +21.5% | 0.00% | – |
| Q1 2023 | $1,256,000 | +24850.3% | 49,377 | -71.4% | 0.00% | -100.0% |
| Q4 2022 | $5,034 | -99.6% | 172,359 | +148.9% | 0.00% | – |
| Q3 2022 | $1,421,000 | +567.1% | 69,258 | +277.7% | 0.00% | – |
| Q2 2022 | $213,000 | -38.3% | 18,339 | -1.8% | 0.00% | – |
| Q1 2022 | $345,000 | +33.7% | 18,666 | +43.2% | 0.00% | – |
| Q4 2021 | $258,000 | – | 13,033 | +130230.0% | 0.00% | – |
| Q1 2021 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,696,340 | $55,302,000 | 8.89% |
| TCG Crossover Management, LLC | 1,164,000 | $23,874,000 | 7.16% |
| VR Adviser, LLC | 2,130,308 | $43,693,000 | 6.74% |
| Fairmount Funds Management LLC | 1,369,623 | $28,091,000 | 4.94% |
| Paradigm Biocapital Advisors LP | 1,636,211 | $33,559,000 | 4.47% |
| Kynam Capital Management, LP | 1,000,000 | $20,510,000 | 4.32% |
| Vivo Capital, LLC | 1,660,019 | $34,047,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 362,735 | $7,440,000 | 3.20% |
| Ghost Tree Capital, LLC | 535,000 | $10,973,000 | 3.08% |
| Logos Global Management LP | 1,000,000 | $20,510,000 | 2.52% |